| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Immunology |
Radiation Biology Branch [Y. V., W. D., D. A. W.], and Laboratory of Cell Regulation and Carcinogenesis [L. C., S-J. K., B. R.], National Cancer Institute, Bethesda, Maryland 20892; Life Sciences Division, Lawrence Berkeley Laboratory, Berkeley, California 94720 [H. C., M. H. B-H.]; Laboratory of Neurotoxicology, National Institute of Mental Health, Bethesda, Maryland 20892 [J. T. S.]; and Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 [G. W. C.]
Many tumor cells or their secreted products suppress the function of tumor-infiltrating macrophages. Tumor cells often produce abundant transforming growth factor ß1 (TGF-ß1), which in addition to other immunosuppressive actions suppresses the inducible isoform of NO synthase. TGF-ß1 is secreted in a latent form, which consists of TGF-ß1 noncovalently associated with latency-associated peptide (LAP) and which can be activated efficiently by exposure to reactive oxygen species. Coculture of the human lung adenocarcinoma cell line A549 and ANA-1 macrophages activated with IFN-
plus lipopolysaccharide resulted in increased synthesis and activation of latent TGF-ß1 protein by both A549 and ANA-1 cells, whereas unstimulated cultures of either cell type alone expressed only latent TGF-ß1. We investigated whether exposure of tumor cells to NO influences the production, activation, or activity of TGF-ß1. A549 human lung adenocarcinoma cells exposed to the chemical NO donor diethylamine-NONOate showed increased immunoreactivity of cell-associated latent and active TGF-ß1 in a time- and dose-dependent fashion at 2448 h after treatment. Exposure of latent TGF-ß1 to solution sources of NO neither led to recombinant latent TGF-ß1 activation nor modified recombinant TGF-ß1 activity. A novel mechanism was observed, however: treatment of recombinant LAP with NO resulted in its nitrosylation and interfered with its ability to neutralize active TGF-ß1. These results provide the first evidence that nitrosative stress influences the regulation of TGF-ß1 and raise the possibility that NO production may augment TGF-ß1 activity by modifying a naturally occurring neutralizing peptide.
This article has been cited by other articles:
![]() |
P. Bautista-Garcia, L. G. Sanchez-Lozada, M. Cristobal-Garcia, E. Tapia, V. Soto, Ma. C. Avila-Casado, R. Marquez-Velasco, R. Bojalil, M. Franco, and J. Herrera-Acosta Chronic inhibition of NOS-2 ameliorates renal injury, as well as COX-2 and TGF-{beta}1 overexpression in 5/6 nephrectomized rats Nephrol. Dial. Transplant., November 1, 2006; 21(11): 3074 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Boxall, S. T. Holgate, and D. E. Davies The contribution of transforming growth factor-{beta} and epidermal growth factor signalling to airway remodelling in chronic asthma Eur. Respir. J., January 1, 2006; 27(1): 208 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Debacq-Chainiaux, C. Borlon, T. Pascal, V. Royer, F. Eliaers, N. Ninane, G. Carrard, B. Friguet, F. de Longueville, S. Boffe, et al. Repeated exposure of human skin fibroblasts to UVB at subcytotoxic level triggers premature senescence through the TGF-{beta}1 signaling pathway J. Cell Sci., February 15, 2005; 118(4): 743 - 758. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shao, M. Folkard, B. D. Michael, and K. M. Prise Targeted cytoplasmic irradiation induces bystander responses PNAS, September 14, 2004; 101(37): 13495 - 13500. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Bechara, L. A. S. Brown, J. Roman, P. C. Joshi, and D. M. Guidot Transforming Growth Factor {beta}1 Expression and Activation Is Increased in the Alcoholic Rat Lung Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 188 - 194. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Waldow, K. Alexiou, W. Witt, F. M. Wagner, V. Gulielmos, K. Matschke, and M. Knaut Attenuation of Reperfusion-Induced Systemic Inflammation by Preconditioning With Nitric Oxide in an In Situ Porcine Model of Normothermic Lung Ischemia Chest, June 1, 2004; 125(6): 2253 - 2259. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Shao, V. Stewart, M. Folkard, B. D. Michael, and K. M. Prise Nitric Oxide-Mediated Signaling in the Bystander Response of Individually Targeted Glioma Cells Cancer Res., December 1, 2003; 63(23): 8437 - 8442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Luckhart, A. L. Crampton, R. Zamora, M. J. Lieber, P. C. Dos Santos, T. M. L. Peterson, N. Emmith, J. Lim, D. A. Wink, and Y. Vodovotz Mammalian Transforming Growth Factor {beta}1 Activated after Ingestion by Anopheles stephensi Modulates Mosquito Immunity Infect. Immun., June 1, 2003; 71(6): 3000 - 3009. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsutsumi, W. Tomisato, T. Hoshino, T. Tsuchiya, and T. Mizushima Transforming Growth Factor-{beta}1 Is Responsible for Maturation-Dependent Spontaneous Apoptosis of Cultured Gastric Pit Cells Experimental Biology and Medicine, June 1, 2002; 227(6): 402 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Goodrum and J. Poulson-Dunlap Cytokine Responses to Group B Streptococci Induce Nitric Oxide Production in Respiratory Epithelial Cells Infect. Immun., January 1, 2002; 70(1): 49 - 54. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. KELLY, R. E. GILBERT, A. J. COX, T. SOULIS, G. JERUMS, and M. E. COOPER Aminoguanidine Ameliorates Overexpression of Prosclerotic Growth Factors and Collagen Deposition in Experimental Diabetic Nephropathy J. Am. Soc. Nephrol., October 1, 2001; 12(10): 2098 - 2107. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pelaez, J. A. Campillo, J. A. Lopez-Asenjo, and J. L. Subiza Cyclophosphamide Induces the Development of Early Myeloid Cells Suppressing Tumor Cell Growth by a Nitric Oxide-Dependent Mechanism J. Immunol., June 1, 2001; 166(11): 6608 - 6615. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Perez-Sala, E. Cernuda-Morollon, M. Diaz-Cazorla, F. Rodriguez-Pascual, and S. Lamas Posttranscriptional regulation of human iNOS by the NO/cGMP pathway Am J Physiol Renal Physiol, March 1, 2001; 280(3): F466 - F473. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |